Citigroup Maintains Buy on Sotera Health, Raises Price Target to $25
Citigroup analyst Brendan Digan maintains Sotera Health (NASDAQ:SHC) with a Buy and raises the price target from $23 to $25.
Read original at benzingaStocks · News reference
8-K filing — Sotera Health Co (SHC)
Filed: 2026-08-14 AccNo: 0001822479-26-000050 Size: 141 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 14, 2026, 11:17 AM
- Checked
- Aug 14, 2026, 11:17 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $22
Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $19 to $22.
Read original at benzingaPiper Sandler Reiterates Overweight on Sotera Health, Raises Price Target to $25
Piper Sandler analyst Jason Bednar reiterates Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $22 to $25.
Read original at benzinga